- Entry
- $4.85
- Now
- $4.85 +0.0%
- Target
- —
- Score
- —
Optimi Health (Nasdaq: OPTH) is a Health Canada-licensed manufacturer of GMP-grade psilocybin and MDMA capsules. Most psychedelic stocks are pre-revenue and dependent on trials. Optimi already sells finished-dose product to clinics in Australia, and it uplisted to Nasdaq in May 2026. What the company does Optimi manufactures finished-dose psilocybin and MDMA capsules at two facilities in Princeton, British Columbia. It holds a Health Canada Drug Establishment Licence, Dealer's Licence and Precursor Licence. Together these allow it to manufacture, test, package …
— ORIGINAL POST ·
OPTH (Optimi Health) – DD on a psychedelic drug manufacturer that’s already generating revenue
· r/pennystocks
· Sep 28, 2026